chr11-72822885-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_033388.2(ATG16L2):āc.748A>Gā(p.Arg250Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,576,598 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_033388.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATG16L2 | NM_033388.2 | c.748A>G | p.Arg250Gly | missense_variant | 7/18 | ENST00000321297.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATG16L2 | ENST00000321297.10 | c.748A>G | p.Arg250Gly | missense_variant | 7/18 | 1 | NM_033388.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152034Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000206 AC: 39AN: 189724Hom.: 1 AF XY: 0.000256 AC XY: 26AN XY: 101426
GnomAD4 exome AF: 0.000181 AC: 258AN: 1424446Hom.: 4 Cov.: 31 AF XY: 0.000223 AC XY: 157AN XY: 704856
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2022 | The c.748A>G (p.R250G) alteration is located in exon 7 (coding exon 7) of the ATG16L2 gene. This alteration results from a A to G substitution at nucleotide position 748, causing the arginine (R) at amino acid position 250 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at